Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Inmagene Biopharmaceuticals
company
About
It is a leading biotech company focused on immunology-related therapeutic areas.
- 51 - 100
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $100M
- Industries
- Biopharma,Biotechnology,Health Care
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$100M
Inmagene Biopharmaceuticals has raised a total of
$100M
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2021 | Series C | $100M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Inmagene Biopharmaceuticals is funded by 1 investors.
Kunlun Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
